PMID: 11604584Oct 18, 2001Paper

Treatment of autoimmune hemolytic anemias

Current Opinion in Hematology
L D Petz

Abstract

Treatment of autoimmune hemolytic anemias varies depending on whether the patient has autoimmune hemolytic anemia of warm antibody type, cold agglutinin syndrome, paroxysmal cold hemoglobinuria, or autoimmune hemolytic anemia secondary to an underlying disorder. Initial therapy for warm antibody autoimmune hemolytic anemia should be corticosteroids, such as prednisone at conventional doses of 1 to 1.5 mg/kg/d orally. Criteria must be established to determine whether the therapeutic response is adequate, because long-term therapy may lead to significant detrimental side effects. Splenectomy has the advantage over therapeutic options in that it has the potential for complete and long-term remission. The major adverse effect is the syndrome of overwhelming postsplenectomy infection. Other therapeutic options, which are less likely to have long-term benefit, are immunosuppressive drugs, danazol, intravenous immunoglobulin, and plasma exchange. Therapy of cold agglutinin syndrome often is unsatisfactory. All patients should avoid exposure to cold, and if additional therapy is necessary, the therapies used for warm antibody autoimmune hemolytic anemia may be tried with less likelihood of response. Paroxysmal cold hemoglobinuria requi...Continue Reading

References

Jun 30, 1977·The New England Journal of Medicine·A D SchreiberM Goldwein
Jan 1, 1991·Acta Haematologica·S DündarO Ozcebe
Aug 1, 1991·Seminars in Arthritis and Rheumatism·J R Caldwell, D E Furst
Jun 1, 1991·The British Journal of Surgery·G L CullingfordD F Mallon
Jan 1, 1990·Acta Haematologica·Y S Ahn
Nov 1, 1990·British Journal of Haematology·C HershkoJ Ashkenazi
Jun 1, 1989·Annals of Emergency Medicine·M Tenenbein
Jun 1, 1988·Australian and New Zealand Journal of Medicine·J Gibson
Dec 1, 1987·Australian and New Zealand Journal of Medicine·A Manoharan
Feb 1, 1987·Annals of Internal Medicine·L E SilbersteinA D Schreiber
May 1, 1985·Archives of Surgery·W W Coon
Aug 1, 1995·Annals of Hematology·R NananH I Huppertz
Feb 1, 1995·Annals of Internal Medicine·R F Schilling
Jan 1, 1993·Journal of Clinical Apheresis·D D KiprovB C McLeod
Jan 1, 1993·Journal of Clinical Apheresis·B C McLeodH G Klein
Dec 15, 1993·Annals of Internal Medicine·D T BoumpasJ E Balow
Jan 8, 1994·BMJ : British Medical Journal·P J Flegg
Feb 1, 1993·British Journal of Haematology·J M PignonH Rochant
Feb 17, 1996·BMJ : British Medical Journal·UNKNOWN Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force
May 1, 1996·British Journal of Haematology·G EmiliaM Bertesi
Dec 1, 1996·American Journal of Hematology·A Jacobs
Dec 1, 1996·Infectious Disease Clinics of North America·A M Lynch, R Kapila
May 20, 1998·Dermatologic Clinics·R S LesterN H Shear
Oct 17, 1998·Clinical Reviews in Allergy & Immunology·C Hashimoto
Oct 27, 1998·Journal of Pediatric Hematology/oncology·A M FriedmannJ F Casella
Nov 3, 1998·The British Journal of Ophthalmology·R M Stanbury, E M Graham
May 13, 1999·Critical Care Medicine·M L Brigden, A L Pattullo
Apr 15, 2000·Journal of Clinical Apheresis·A P Koo
Apr 15, 2000·Journal of Clinical Apheresis·K M Grima
Mar 10, 2001·Indian Journal of Pediatrics·J P Isbister

❮ Previous
Next ❯

Citations

May 22, 2013·Archivum Immunologiae Et Therapiae Experimentalis·José Carlos Jaime-PérezDavid Gómez-Almaguer
Jun 8, 2010·Annals of Hematology·Francisco Javier PeñalverUNKNOWN Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA
Oct 12, 2011·Journal of Veterinary Internal Medicine·K F McGovernR Tan
Sep 6, 2014·Singapore Medical Journal·Shashvat Sukhal, Shweta Gupta
Feb 10, 2016·Annals of Hematology·Kamel LaribiAlix Baugier de Materre
Nov 19, 2013·Pediatric Clinics of North America·David T Teachey, Michele P Lambert
May 17, 2011·European Journal of Internal Medicine·Wilma Barcellini, Alberto Zanella
Mar 20, 2009·La Presse médicale·Guillaume BussoneLuc Mouthon
Apr 5, 2008·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Fabio AgliecoAndre A Kaplan
Mar 6, 2008·British Journal of Haematology·Bernadette Garvey
May 7, 2010·Transplant International : Official Journal of the European Society for Organ Transplantation·Gonzalo BotijaGerardo Prieto
Jun 23, 2010·Journal of Clinical Apheresis·Zbigniew M SzczepiorkowskiUNKNOWN Apheresis Applications Committee of the American Society for Apheresis
Mar 6, 2010·Journal of Internal Medicine·F PerosaF Dammacco
Aug 8, 2006·International Journal of Cardiology·Yun ZhangDanchen Gao
Jul 26, 2005·Seminars in Hematology·Karen E King, Paul M Ness
Jul 15, 2015·Autoimmunity Reviews·M Lecouffe-DespretsM Hamidou
Oct 10, 2013·Clinical & Developmental Immunology·Bainan Liu, Wangang Gu
Jul 5, 2003·The Annals of Pharmacotherapy·Young R OhPeter G Crawley
Aug 2, 2007·Obstetrics and Gynecology·Simi DhingraHelen Jackson
Mar 31, 2007·Journal of Clinical Apheresis·Zbigniew M SzczepiorkowskiUNKNOWN Apheresis Applications Committee of the American Society for Apheresis
Sep 28, 2007·Current Opinion in Hematology·Bruce C McLeod
May 13, 2008·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Elisabetta RodellaRossella Paolini
Apr 14, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·F LacailleF M Ruemmele
Dec 1, 2008·Expert Review of Hematology·Pascal SèveMarc Michel
Feb 1, 2005·American Journal of Hematology·S RamanathanM S Hertzberg
Mar 8, 2006·World Journal of Gastroenterology : WJG·Themistoklis VassiliadisNikolaos Eugenidis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

American Journal of Hematology
Bradley C Gehrs, Richard C Friedberg
Seminars in Hematology
K E King, Paul M Ness
British Journal of Haematology
J M PignonH Rochant
© 2021 Meta ULC. All rights reserved